Research shows overall survival benefit for patients with Stage III soft tissue sarcomas
Fox Chase Cancer Center researchers have carried out the first retrospective analysis of adjuvant chemotherapy's impact on overall survival in patients with stage III soft tissue sarcomas (STS), adjusted for socioeconomic ...
May 30, 2014
0
0